Efficacy of TJ-45 for postoperative delirium in elderly patients undergoing gastroenterological cancer surgery

Efficacy of TJ-45 for postoperative delirium in elderly patients undergoing gastroenterological cancer surgery - Prevention of postoperative delirium in elderly patients

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027967

Enrollment

290

Registered

2017-09-01

Start date

2017-11-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroenterological cancer

Interventions

No treatment TJ-45

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 75 years old or older patients with gastroenterological cancer 2. elective surgery patients 3. scheduled for laparotomy or laparoscopic surgery 4. PS 0-2 5. adequate organ function

Exclusion criteria

Exclusion criteria: 1. unable to eat foods 2. scheduled for thoracotomy or tholacoscopic surgery 3. double cancer 4. Antipsychotics, antidepressant, or narcotics medication within 6 months 5. dementia

Design outcomes

Primary

Measure	Time frame
Incidencnce of postoperative delirium	—

Secondary

Measure	Time frame
Postoperative complications, duration of postoperative hospital stay, outcome at discharge, changes G8 score and cognitive function, nutrtional status, prognosis	—

Countries

Japan

Contacts

Public ContactMasaaki Motoori

Osaka General Medical Center Surgery

mmotoori@gh.opho.jp06-6692-1201

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026